Abstract: Semaphorins were originally identified as axon guidance cues involved in the development of the nervous system. In recent years, it is emerging that they also participate in various biological systems, including physiological and pathological processes. In this review, we primarily focus on our cumulative findings for the role of semaphorins and their receptors in the regulation of the immune system, while also summarizing recent progress in the context of cardiovascular system.
Introduction
Cumulative findings indicate that the nervous and immune systems have considerable overlap and links. 1) For example, some axon guidance molecules, such as slits and ephrins, have been shown to regulate immune cell migration.
2), 3) In addition, T-cell-antigen-presenting cell contact sites, the so-called 'immunological synapse', are structurally similar to the 'neurological synapse' that connects pairs of neurons. These shared molecules and interactions play critical roles in inducing proper immune responses.
Semaphorins were named for properties that are analogous to the system of flags and lights that is used in rail and maritime communication. They were initially identified as repulsive axon guidance factors that direct neuronal axons to their appropriate targets. 4) To date, more than 20 types of semaphorins have been identified, and they have diverse functions in many physiological processes, including cardiogenesis, 5) angiogenesis, 6) vasculogenesis, 7) tumor metastasis, 8) osteoclastogenesis, 9) and immune regulation. 10) We isolated the cDNA of Sema4D through the search for CD40 (an immune co-stimulatory molecule)-inducible genes by subtractive PCR-cloning. In addition, we isolated the cDNA of Sema6D from the cDNA library of the heart by PCR-cloning using degenerative primers. The identification of Sema4D and Sema6D has clarified the important roles of the semaphorin family in the immune and cardiac systems, respectively. Here, we review the pleiotropic functions of semaphorins, primarily focusing on their roles in immune responses and cardiac morphogenesis.
Semaphorins and their receptors
Semaphorins are secreted and membrane-associated proteins that are characterized by a conserved extracellular amino-terminal 'Sema' domain. Based on their C-terminal structures, this diverse group of proteins has been further divided into eight subclasses. 11) Semaphorins in classes I (invertebrate) and IV-VII are membrane-associated, whereas those in classes II (invertebrate), III, and VIII (virally encoded) are secreted. Two groups of proteins, plexins and neuropilins (NPs), have been identified as the primary semaphorin receptors.
12)-14) Most membrane-bound semaphorins directly bind plexins, whereas class III semaphorins require NPs as obligate coreceptors. However, increasing evidence has shown that semaphorin receptor usage is more complex than previously thought. 15) For example, Sema3E signals independently of NPs through plexin-D1, 7) while Sema7A uses integrins to exert its functions in both the nervous and immune systems. 16 ), 17) In addition, two molecules unrelated to plexins and NPs, CD72 18) and T-cell immunoglobulin and mucin domain containing protein 2 (TIM-2), 19) functionally interact with Sema4D and Sema4A, respectively, in the immune system (Fig. 1) .
Plexins are canonical semaphorin receptors that have large cytoplasmic domains. In the nervous system, plexin-mediated signals have been shown to exert diverse neural functions by regulating GTPase activities and cytoplasmic/receptor-type protein kinases. 20) These signals are also involved in integrin-mediated attachment. 21)-23) Of note, plexins can associate with different co-receptors in distinct tissues to allow semaphorins to exert pleiotropic functions. For instance, plexin-A1 is associated with the tyrosine kinase receptors off-track (OTK) and vascular endothelial growth factor receptor 2 (VEGFR2) in heart morphogenesis. 24) In another context, plexin-A1 forms a receptor complex with triggering receptor expressed on myeloid cell (TREM)-2/DNAX-activating protein 12 (DAP12) during osteoclastogenesis. 9) Furthermore, plexin-B1 has been shown to associate with the receptor tyrosine kinases Met and ErbB2, inducing invasive growth of epithelial cells. 25) , 26) These observations provide insight into the diversity of semaphorin functions (Fig. 1 ).
Immune semaphorins
(1) Sema4D: a semaphorin involved in B cell/dendritic cell (DC) activation (Fig. 2a) . Sema4D, also known as CD100, is the first sema-
Immune system Non-immune systems In the immune system, Sema4D binds to CD72, which promotes B cell and DC activation. Sema4A recognizes plexin-B and D1 in the non-immune systems but uses TIM-2 as a receptor for T cell activation in the immune system. During cardiogenesis, plexin-A1 associates with OTK or VEGFR2 at distinct sites. However, plexin-A1 forms a receptor complex with TREM-2-DAP12, which is critical for DC activation and osteoclastogenesis. Sema7A has two types of receptors: ,1-1 integrin for macrophage activation and plexin-C1 for inhibition of cell adhesion. Viral semaphorin A39R also recognizes plexin-C1 and modulates dendritic cell function.
phorin protein for which immunoregulatory functions were identified. In the immune system, abundant expression of Sema4D is observed in resting T cells. The basal expression of Sema4D in B cells and DCs is very low, but protein levels are considerably higher following cellular activation. 18),27) Sema4D promotes B cell activation in the context of proliferation and antibody production. Plexin-B1 and CD72 have been identified as Sema4D receptors in the nervous and immune systems, respectively. 14),18),22) CD72 contains two immunoreceptor tyrosine-based inhibitory motifs (ITIM) in its cytoplasmic domain, 28) and is known to function as a negative regulator of B cells through the recruitment of the tyrosine phosphatase SHP-1 to its phosphorylated ITIM. 18) Ligation of Sema4D to CD72 induces dissociation of SHP-1, resulting in B cell activation (Fig. 2a) . Consistently, Sema4D-deficient mice display impaired antibody production, implicating Sema4D in B cell activation. In addition to its involvement in B-cell responses, Sema4D is involved in T cell activation by promoting the activation and maturation of DCs. In fact, Sema4D-deficient mice display impaired generation of antigen-specific T cells.
18),27) Although Sema4D is a transmembrane protein, its extracellular region is proteolytically cleaved from the surface of activated lymphocytes in a metalloprotease-dependent process. 29) Sema4D is also cleaved from the surface of platelets by the metalloprotease ADAM17. 30) Elevated levels of soluble Sema4D protein are detectable in the culture supernatants of activated lymphocytes and in the sera of immunized and autoimmune mice.
29)
(2) Sema4A: a semaphorin involved in both T cell activation and differentiation. Sema4A is another class IV semaphorin. In the immune system, Sema4A is constitutively expressed on DCs.
19) The expression of Sema4A is also detectable in activated T cells and T helper type 1 (Th1)-polarized cells. DCderived Sema4A and T cell-derived Sema4A play different roles during the course of T cell-mediated immunity; in particular, DC-derived Sema4A is crucial for antigen-specific T cell priming, whereas T cell-derived Sema4A is involved in helper T cell differentiation 31) (Fig. 2b) . Indeed, the critical involvement of Sema4A in the differentiation of helper T cells has been demonstrated by the phenotypes of Sema4A-deficient mice. Sema4A deficient mice show impaired responses to heat-killed Propionibacterium acnes, a Th1-inducing agent. In contrast, these mice show enhanced T helper type 2 (Th2) responses against infection of Nippostrongylus brasiliensis, a Th2-inducing intestinal nematode. 31) Furthermore, Sema4A-deficient mice on a Th2-prone BALB/c background spontaneously develop atopic dermatitis (T.M. unpublished data), indicating that Sema4A is involved in the regulation of Th1/Th2 development. Several lines of evidence support a role of TIM-2, which is induced on activated T cells, as a functional receptor for Sema4A.
19) The expression of TIM-2 is preferentially upregulated on T cells during Th2 differentiation. Administration of recombinant TIM-2 protein suppresses the development of experimental autoimmune encephalomyelitis (EAE) is suitable mice immunized with proteolipid protein-derived peptide by inhibiting the generation of Th1 cells. 32) Furthermore, TIM-2-deficient mice show exacerbated lung inflammation accompanied by dysregulated Th2 responses. 33 ) It thus appears that Sema4A-TIM-2 interactions negatively regulate Th2 responses. However, there are some phenotypic differences between Sema4A-deficient and TIM-2-deficient mice. For example, T cells from TIM-2-deficient mice but not from Sema4A-deficient mice show enhanced basal proliferation. This observation raises the possibility that Sema4A and/or TIM-2 have other binding partners. Indeed, T cells express members of the plexin-B family and plexin-D1, both of which have Sema4A-binding activities. 34) (3) Sema6D and plexin-A1: an interaction involved in the T cell-dendritic cell interface and osteoclastogenesis.
Plexins are the canonical/ primary semaphorin receptors during the development of the nervous and cardiovascular systems. Class III semaphorins bind a receptor complex formed by plexin-A1 and NP-1. Additionally, plexin-A1 serves as a direct binding receptor for the class VI semaphorins, Sema6C and Sema6D. 24) , 35) In the immune system, plexin-A1 is specifically expressed by DCs.
36) The function of plexin-A1 in DCs has been shown using RNA interference and by analysis of plexin-A1-deficient mice. 9),36) 'Knockdown' of plexin-A1 in DCs by short hairpin RNA impairs their ability to activate T cells in vitro and in vivo. In addition, plexin-A1-deficient DCs are poor at stimulating antigen-specific T cells. 36) In vivo, plexin-A1-deficient mice show impaired T cell-priming. 9) These observations indicate that plexin-A1 expression in DCs is required for the initial activation and efficient generation of antigen-specific T cells. It is worthy of note that plexin-A1-deficient mice develop osteopetrosis as a result of decreased bone resorption due to defective osteoclastogenesis. 9) Sema6D was suggested to be a ligand for plexin-A1. Indeed, recombinant Sema6D protein binds to and activates DCs, and this activity is profoundly attenuated in plexin-A1-deficient DCs. These observations suggest that Sema6D-expression on T cells is involved in DCactivation. The expression of Sema6D is also observed in osteoclasts. Recombinant Sema6D protein enhances in vitro osteoclastogenesis, suggesting that Sema6D and plexin-A1 might function in osteoclastogenesis in an osteoclast-autonomous manner. Plexin-A1 forms a receptor complex with TREM-2 and the adaptor molecule DAP12 in DCs and osteoclasts. 9) Interestingly, DAP12-deficient mice show impaired T cell responses and develop osteopetrosis, 37) and genetic mutations in human DAP12 or TREM-2 result in a bone fracture syndrome called Nasu-Hakola disease, 38) supporting the idea that plexin-A1 physiologically associates with the TREM-2/DAP12 complex.
(4) Sema7A: a semaphorin involved in inflammatory responses. Sema7A, also known as CD108, is a membrane-associated GPI-anchored protein. 39) In the nervous system, Sema7A has been shown to promote olfactory bulb axon outgrowth and is required for the proper formation of the lateral olfactory tract during embryonic development. 16) Plexin-C1 was initially identified as a receptor for Sema7A. 14) However, in its Sema domain, Sema7A contains an arginine-glycine-aspartate sequence that is a well conserved integrin-binding motif, and it exerts its function through -1 integrin, not through plexin-C1. 16) In the immune system, the expression of Sema7A is induced on activated T cells, and it is involved in T cell-mediated inflammatory immune responses. 17) Recombinant Sema7A protein stimulates monocytes/macrophages through ,1-1 integrin, also known as very late antigen-1, inducing the production of proinflammatory cytokines 17) (Fig. 2c) . Consistently, Sema7A-deficient mice are resistant to the development of inflammation, including hapteninduced contact hypersensitivity and experimental autoimmune EAE. 17) These observations indicate that interactions between Sema7A and ,1-1 integrin are crucial for T cell-mediated macrophage activation at sites of inflammation. Plexin-C1 is also expressed in macrophages; however, recombinant Sema7A protein induces normal production of proinflammatory cytokines in plexin-C1-deficient macrophages (unpublished data). Therefore, at least for T cellmacrophage interactions, ,1-1 integrin but not plexin-C1 seems to be the predominant receptor for Sema7A, implying that integrin-mediated signaling is a common mechanism for Sema7A functions in both the nervous and immune systems.
(5) Sema3A and plexin-A4: a semaphorin and semaphorin receptor required for negative regulation of T cell responses. Sema3A was the first semaphorin identified in vertebrates. Sema3A directly binds to NP-1, inducing the activation of plexin-A proteins and the transduction of axon repulsive signals. Several lines of evidence suggest that Sema3A also functions in the immune system (Fig. 1, Table 1 ). The expression of Sema3A is detected in activated DCs, T cells, and some tumor cells. Sema3A inhibits spontaneous monocyte migration in vitro. In addition, Sema3A suppresses T cell proliferation by inhibiting actin cytoskeletal reorganization and downregulating MAPK signaling. 40) Furthermore, Sema3A-deficient T cells exhibit enhanced in vitro proliferative responses to anti-CD3 antibodies. 41) These observations suggest that Sema3A serves as a negative regulator of T cells. Similar to other plexin-A proteins, plexin-A4 forms a receptor complex with NP-1 to transduce class III semaphorin-mediated signaling or directly binds to Sema6A. 42) Plexin-A4-deficient T cells exhibit hyperproliferation and enhanced TCR signals upon anti-CD3 stimulation. Furthermore, plexin-A4-deficient mice show enhanced T cell priming and exacerbated T cell-mediated immune responses such as EAE. 41) Therefore, plexin-A4 might interact with Sema3A in the immune system and this interaction might negatively regulate T cell responses. However, it remains unclear how plexin-A4 negatively regulates T cells and whether other semaphorins are relevant to plexin-A4-mediated immune responses.
(6) NP-1: a marker for regulatory T cells. As described above, NP-1 was originally identified as a cell surface glycoprotein that acts as a class III semaphorin receptor. NP-1 is also known as human DC-specific antigen (blood DC antigen)-4, a specific plasmacytoid DC marker in humans, and was assigned CD304. In the immune system, the expression of NP-1 was observed in DCs and T cells. 43) NP-1 is thought to be involved in the initiation of primary immune responses through a homophilic interaction at contact sites between T cells and DCs. In addition, NP-1 has been identified as a specific marker for CD4 + CD25 + regulatory T (Treg) cells. 44) Indeed, NP-1 is a member of the group of forkhead box P3 (Foxp3)-inducible genes, which also includes CD25, glucocorticoid-induced tumor necrosis factor receptor-related protein, and cytotoxic T-lymphocyte antigen-4 (CTLA-4). 44) More recently, it has been suggested that NP-1 in Treg cells contributes to the long contact between Treg cells and DCs compared with the shorter contact between naive T cells and DCs. Treg cells made stable contacts with DCs that preceded the contact of naive T cells with DCs; this might lead to the inhibition of T-cell activation at steady state. 45) The finding that Treg cells are endowed with the ability to have long interactions with DCs mediated by NP-1 supports the idea that NP-1 might contribute to physical interactions between T cells and DCs.
Semaphorins in cardiac morphogenesis
Cumulative findings also indicate the significance of semaphorins in the development of other organ systems, such as the cardiovascular system, in which some semaphorins control the migration of endothelial cells, cardiac myocytes, or their precursors. 24 ),34),46),47)
(1) Sema6D-Plexin-A1 in cardiac morphogenesis. One of the best characterized roles of a semaphorin in cardiac development is that of Sema6D, which belongs to the class VI transmembrane-type semaphorin subfamily. In mice, the expression of Sema6D is first detected in the cardiac crescent and neural fold of E9 embryos.
24) The roles of Sema6D in the developing heart have been revealed by a series of studies using the chick embryo system. Inoculation of transfected cells that release a large amount of soluble Sema6D into cultured chick embryos at Hamberger and Hamilton (HH) stage 9 results in enhanced looping of the cardiac tube and enlargement of the ventricular region. In ovo inoculation of Sema6D producing cells or recombinant soluble Sema6D into HH stage 29 embryos results in an expanded ventricular cavity with a thin myocardial layer and an enlarged endocardial cushion. In contrast, RNAi-mediated knockdown of Sema6D inhibits looping of the cardiac tube. 24) In this context, Sema6D signals are largely mediated through Plexin-A1, which is also expressed in the embryonic heart. Indeed, RNAi-mediated knockdown of Plexin-A1 or expression of truncated Plexin-A1 resulted in shrunken ventricles. 24) Therefore, the Sema6D-Plexin-A1 axis is critically involved in the dynamic remodeling of the cardiac tube and formation of the ventricle and endocardial cushion.
(2) Sema6D exerts distinct biological activities in endothelial cells in different regions of the cardiac tube. Sema6D inhibits the migration of outgrowing cells from the ventricle segment. In contrast, Sema6D promotes the migration of outgrowing cells from the conotruncal and atrioventricular valve segments, which later fuse to form the endocardial cushion. These biological activities of Sema6D appear to be mediated through Plexin-A1, as they are abrogated by RNAi-mediated knockdown of Plexin-A1 or expression of truncated Plexin-A1 in endothelial cells from the ventricle or conotruncal segments. 24) Interestingly, we have demonstrated that Plexin-A1 forms a complex with OTK in the endothelial cells of the ventricular region of the cardiac tube, whereas it forms a complex with VEGFR2 in endothelial cells of the conotruncal segments. Further, the Sema6D-induced migration of endothelial cells is suppressed both by RNAi against Plexin-A1 and by RNAi against VEGFR2. 24) This differential association of Plexin-A1 with additional receptor components allows Sema6D to exert distinct biological activities in adjacent regions, which is critical for complex cardiac morphogenesis.
(3) Reverse signaling of Sema6D in the cardiac ventricle. Among the semaphorin family members, class VI semaphorins are unique because of their relatively long cytoplasmic regions, which may imply the existence of reverse signaling. Indeed, it has been reported that the Sema6A cytoplasmic region can associate with two molecules, 48) Abl kinase and Enabled (Ena), a member of the Ena/VASP family. Abl kinase and Ena are known to play opposing roles downstream of drosophila Robo, an axon guidance receptor for Slit. 49) Ena has also been implicated in reverse signaling of drosophila Sema1a. 50) Upon binding to the ectodomain of Plexin-A1, Abl kinase is recruited to the cytoplasmic tail of Sema6D and activated, resulting in phosphorylation of Ena and dissociation from Sema6D. 46) In the case of fatemapping studies using myocardial cells, cells carrying defects in Sema6D reverse signaling arrest in the compact layer, while expression of constitutively active Abl kinase enhances the migration of cells from the compact layer to the trabeculae. 46) Thus, class VI semaphorins transduce reverse signals through their cytoplasmic domains to regulate biological output.
Semaphorin-mediated signals
in endothelial cell migration
As described above, the class III semaphorins exert pleiotropic functions through NP-1/Plexin-A receptor complexes, which regulate small GTPases and integrins. 21 ),51),52) However, the molecular mechanisms underlying this regulation/integration have remained unclear.
We have determined that the FERM domaincontaining guanine nucleotide exchange factor (GEF) FARP2 functions as an immediate downstream signal transducer of the Plexin-A1-NP-1 receptor complex in Sema3A-mediated repulsion of neuronal axons. 23) Sema3A-induced dissociation of FARP2 from Plexin-A1 and activation of its Rac-GEF activity triggers a series of biochemical events, including Rac activation and the binding of Rnd1, a member of the Rho GTPase family, to Plexin-A1. This binding stimulates the GAP activity of Plexin-A1 for R-Ras, a member of the Ras GTPase family. The down-regulation of R-Ras leads to the cytoskeletal disassembly that is critical for Plexin-A1-mediated growth cone collapse. 22) In parallel with this event, dissolved FARP2 competes with an isoform of type-1 phosphatidylinositol phosphate kinase, PIPKI.661, for the FERM domain of talin. PIP 2 generated by PIPKI.661 in association with talin is important for the stability of integrinmediated focal adhesions, 53) , 54) and the inhibition of PIPKI.661 kinase activity by FARP2 binding downregulates integrin function. Thus, semaphorin-Plexin signaling is involved in cardiac morphogenesis by regulating cytoskeletal dynamics and cell-matrix interactions.
Perspectives
Accumulating evidence reveals that several semaphorins and their receptors have multiple biological activities. These semaphorins form a family of immunoregulatory molecules, called 'immune semaphorins' (Fig. 3, Table 1 ). Indeed, the lack of semaphorin family proteins results in several immune disorders, including autoimmune diseases, allergy, and congenital bone disease. Lack of these proteins also causes unresponsiveness to physiological immune responses (Table 1) . Therefore, semaphorin family proteins are at least involved in immunological homeostasis, based on sophisticated immune cell communication systems. Furthermore, the patterning and morphogenesis of the heart, as regulated by semaphorins and their receptors are discussed in this review. However, the molecular information available in this context remains fragmented. To understand heart development further, we should complete the definition of the molecular systems required for its formation, and then seek the points of integration between these systems. Several important issues remain to be resolved. Although semaphorins function to regulate cell motility and morphology by activating plexins, most of the immunological studies of semaphorins have only focused on their costimulatory effects. However, it is plausible that semaphorins exert their functions by affecting the cytoskeleton. Further studies are required to clarify the role of semaphorins in cell-cell interactions, cell morphology, and dynamics, both in the immune system and cardiac morphogenesis. Finally, understanding of semaphorins and their receptors should allow pharmacological modulation of their functions, and may lead to the identification of potential therapeutic targets for several human diseases.
